Regulation, and the interpretation of existing rules, of cannabis in all its forms, is a recurring subject in France, and one that is set to continue following the Court of Justice of the European Union (CJEU)’s recent decision in the Kanavape case. Aside from changes relating to that, there are a number of other proposals relating to France’s medical cannabis regime. This report provides a detailed overview of all current and possible future regulations. The CJEU’s recent ruling is likely to have deep consequences for Europe’s CBD industry, and while France has not released an interpretation yet, the government will have no choice but to adapt to the ruling. This report will provide you with everything you need to know about France’s regulatory framework for CBD and cannabis, from the processing and cultivation of hemp to the country’s medical and recreational regimes.

Mmp News Author, Medical Marijuana Program Connection, 06/12/2021 01:46:00

Open article: